Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Novel cell death program leads to neutrophil extracellular traps
2007 Standout
Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
2016 Standout
Beta‐lactam plus macrolides or beta‐lactam alone for community‐acquired pneumonia: A systematic review and meta‐analysis
2016
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Infective Endocarditis
2005 Standout
Cochrane Database of Systematic Reviews
2003 Standout
Prognosis and Outcomes of Patients With Community-Acquired Pneumonia
1996
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical Outcome
2003
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
High Alcohol Intake as a Risk and Prognostic Factor for Community-Acquired Pneumonia
1995
Erythromycin-resistant Beta-hemolytic Streptococci Group A in Goteborg, Sweden
1988
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.
1996
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
2005
Treatment of Community-Acquired Pneumonia in Outpatients: Randomized Study of Clarithromycin Alone versus Clarithromycin and Cefuroxime
1999
A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies
2004
DIAGNOSTIC TESTING FOR COMMUNITY-ACQUIRED PNEUMONIA
1999
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Time to resolution of morbidity: an endpoint for assessing the clinical cure of community-acquired pneumonia
1996
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
2001 StandoutNature
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
1997 Standout
Capsule and d-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps
2007
Deaths in Bacteremic Pneumococcal Pneumonia
1993
Diagnostic value of bronchoalveolar lavage in patients with opportunistic and nonopportunistic bacterial pneumonia
1993
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
1997
Clinical applications of C-reactive protein in pediatrics
1997 Standout
Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
1998
Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP – Results from the German competence network CAPNETZ
2009
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study
2003 Standout
Effect of body mass index on the outcome of infections: a systematic review
2009
Community-Acquired Pneumonia Due to Gram-Negative Bacteria and Pseudomonas aeruginosa
2002
Serum C-reactive Protein in the Differential Diagnosis of Acute Meningitis
1993
A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study
2010
Processes and Outcomes of Care for Patients With Community-Acquired Pneumonia
1999
Diagnostic Fiberoptic Bronchoscopy and Protected Brush Culture in Patients with Community-Acquired Pneumonia
1990
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
The Science of Antibiotic Discovery
2020 Standout
Pneumolysin: A multifunctional pneumococcal virulence factor
1998
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care
1998
ASSESSING PROGNOSIS AND SELECTING AN INITIAL SITE OF CARE FOR ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA
1998
Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia
2010
Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases
2005
Outbreaks of Infections with Erythromycin-resistant Group A Streptococci in Child Day Care Centres
1990
Aetiology of community-acquired pneumonia in children treated in hospital
1993
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood
2007 Standout
Once‐Daily Sparfloxacin Versus High‐Dosage Amoxicillin in the Treatment of Community‐Acquired, Suspected Pneumococcal Pneumonia in Adults
1998
Neutrophil extracellular traps in immunity and disease
2017 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
BTS guidelines for the management of community acquired pneumonia in adults: update 2009
2009
Antifungal prophylaxis for severely neutropenic chemotherapy recipients
2002
Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978–1997
1999
Severity prediction rules in community acquired pneumonia: a validation study
2000
An Endonuclease Allows Streptococcus pneumoniae to Escape from Neutrophil Extracellular Traps
2006
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course
1996
Infections in Patients with Diabetes Mellitus
1999 Standout
The epidemiology of community-acquired pneumonia among hospitalized adults
1997
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination
2002
Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials
2005
β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis
2014
Severe Community-Acquired Pneumonia
1994
Actual Causes of Death in the United States, 2000
2004 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy
1999
Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis
1990
Microbial biogeography: putting microorganisms on the map
2006 Standout
Factors associated with unknown aetiology in patients with community-acquired pneumonia
2002
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Penicillin tolerance genes ofStreptococcus pneumoniae: the ABC‐type manganese permease complex Psa
1998 StandoutNobel
Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors.
1996
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
2012
Epidemiology of community-acquired pneumonia in adults: a population-based study
2000
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta‐analysis of randomised‐controlled trials
2005
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Problems in the Design and Reporting of Trials of Antifungal Agents Encountered During Meta-analysis
1999
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Etiology of Community-Acquired Pneumonia:
1999
Pneumonia Acquired in the Community Through Drug-Resistant Streptococcus pneumoniae
1999
Severe Community-acquired Pneumonia
2002
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Antimicrobial Treatment Failures in Patients with Community-acquired Pneumonia
2000
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
2003 Standout
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients
2000
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
2003
Role of Conjugative Elements in the Evolution of the Multidrug-Resistant Pandemic CloneStreptococcus pneumoniaeSpain23FST81
2008
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures
1998
Monoclonal antibody recognizing a species-specific protein from Streptococcus pneumoniae
1990
Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995.
1998
Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins
2014 Standout
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?
2006
Early Exposure to Common Anesthetic Agents Causes Widespread Neurodegeneration in the Developing Rat Brain and Persistent Learning Deficits
2003 Standout
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
The role of pneumolysin in pneumococcal pneumonia and meningitis
2004
Etiological Diagnosis of Bacterial Pneumonia by Gram Stain and Quantitative Culture of Expectorates: Leukocytes or Alveolar Macrophages as Indicators of Sample Representativity
1983
Genomic insights that advance the species definition for prokaryotes
2005 Standout
The Crisis in Antibiotic Resistance
1992 StandoutScience
Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
2000
What are Bacterial Species?
2002
Detection of Streptococcus pneumoniae Antigen by a Rapid Immunochromatographic Assay in Urine Samples
2001
β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia
2014
Identification of Invasive Serotype 1 Pneumococcal Isolates That Express Nonhemolytic Pneumolysin
2006
Antifungal Prophylaxis in Cancer Patients After Chemotherapy or Hematopoietic Stem-Cell Transplantation: Systematic Review and Meta-Analysis
2007
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
2015
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Salmonella typhiFlagella Are Potent Inducers of Proinflammatory Cytokine Secretion by Human Monocytes
1999
Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps
2010 Standout
Testing Strategies in the Initial Management of Patients with Community-Acquired Pneumonia
2003
Diagnosis of Bacterial Infections of the Lung
1987
The Impact of Alcohol-Related Diagnoses on Pneumonia Outcomes
1997
Insertion Sequence 1515 in the ply Gene of a Type 1 Clinical Isolate of Streptococcus pneumoniae Abolishes Pneumolysin Expression
2007 StandoutNobel
Works of M. Kalin being referenced
Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization
1990
Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: A study in 710 patients with suspected central nervous system infection
1988
Comparison of three methods for detection of pneumococcal antigen in sputum of patients with community-acquired pneumonia
1989
Clonal and Capsular Types Decide Whether Pneumococci Will Act as a Primary or Opportunistic Pathogen
2006
Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever — preliminary observations from a pilot, exploratory study
1995
Endotoxemia in febrile patients with hematological malignancies. Relationship of type of bacteremia, clinical findings and serum cytokine pattern
1997
Respiratory tract colonization and incidence of secondary infection during hospital treatment of community-acquired pneumonia
1990
Addition of a macrolide to a ß-lactam in bacteremic pneumococcal pneumonia
2006
Hepatotoxicity due to repeated intake of low doses of paracetamol
1992
Incidence, Capsular Types, and Antibiotic Susceptibility of Invasive Streptococcus pneumoniae in Sweden
1995
Cefepime as Empirical Monotherapy in Febrile Patients with Hematological Malignancies and Neutropenia: A Randomized, Single-Center Phase II Trial
1999
Dynamics of Penicillin‐Susceptible Clones in Invasive Pneumococcal Disease
2001
A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma
2004
Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients
1994
Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels
2008
Detection time for blood culture isolates using a biphasic medium
1983
Diagnosis of pneumococcal pneumonia by enzyme-linked immunosorbent assay of antibodies to pneumococcal hemolysin (pneumolysin)
1987
Diagnosis of pneumococcal pneumonia by coagglutination and counterimmunoelectrophoresis of sputum samples
1982
Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
1983